Superworth

Bausch & Lomb EV/EBIT BLCO

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2023.

Today, Nov 2, 2026
33.9×
4-year median
51.7×
Against its 4-year history
7th
percentile: 0 is its lowest day, 100 its highest
4-year range
30.3× to 193×
Peer median
19.7×

Bausch & Lomb's EV/EBIT is 33.9× as of Nov 2, 2026.

That is below its 4-year median of 51.7×, lower than on 93% of days in the last 4 years.

Over that time it ranged from 30.3× in Oct 2026 to 193× in Oct 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 19.7×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far33.9×30.3×103×
2025103×45.8×193×
202465.6×42.8×71.1×
202353.2×34.3×54.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

CompanyEV/EBIT
BLCOBausch & Lomb33.9×
MSAMSA Safety18.4×
HAEHaemonetics27.1×
MMSIMerit Medical Systems26.0×
VNTVontier11.5×
PODDInsulet21.0×
GMEDGlobus Medical15.9×
ALGNAlign Technology16.2×
BMIBadger Meter26.9×
COOCooper Companies17.2×
ICUIICU Medical44.9×
Peer median19.7×

Where Bausch & Lomb ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.